Court Rules E-cigarette Packaging Warnings not Violate Law in South Korea

Regulations by 2FIRSTS.ai
Mar.14.2024
Court Rules E-cigarette Packaging Warnings not Violate Law in South Korea
Seoul court rules e-cigarette health warnings on packaging lawful; rejects lawsuit against South Korean health institute.

According to a recent report from South Korean media YTN, the Seoul Central District Court ruled on April 21 that e-cigarette packaging with health hazard warning images did not violate the law. The court denied the claims of the plaintiffs in a compensation lawsuit filed by a smokers' rights group against the Korea Health Development Institute.

 

The court stated that although some opinions claim that e-cigarettes pose less harm to health compared to traditional cigarettes, this viewpoint of reduced health risks is not widely accepted. Additionally, the court does not support the government recommending the use of e-cigarettes to the public simply because they may cause less harm.

 

According to a further ruling by the court, the graphic warnings and anti-smoking advertisements regarding the addictive nature and health risks of e-cigarettes are fact-based, and therefore legally sound. In October 2023, a group of smokers' rights activists filed a lawsuit claiming that the warnings on cigarette packages and anti-smoking advertisements violated their rights to smoke, equality, and reputation.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Non-Nicotine Smoking Cessation Drug Cytisinicline Submitted for FDA Review
Non-Nicotine Smoking Cessation Drug Cytisinicline Submitted for FDA Review
Cytisinicline has been submitted for FDA approval and, if approved, would become the first non-nicotine smoking cessation drug in 20 years.
Jul.07 by 2FIRSTS.ai
UK MHRA Releases Database with 329 e-cigarette SKUs, Including Brands like ELFBAR, SKE, OXVA, and INNOKIN
UK MHRA Releases Database with 329 e-cigarette SKUs, Including Brands like ELFBAR, SKE, OXVA, and INNOKIN
The Medicines and Healthcare products Regulatory Agency (MHRA) of the UK announced 329 SKUs in its e-cigarette product notification database between August 2 and August 10, including updates on rechargeable e-cigarettes, open-system e-cigarettes, and multi-flavor pods from brands such as ELFBAR, OXVA, INNOKIN, SKE, and VAPES BARS.
Aug.11 by 2FIRSTS.ai
Special Report | The Global Flavor Shift: How Changing Tastes Are Driving Nicotine Product Innovation
Special Report | The Global Flavor Shift: How Changing Tastes Are Driving Nicotine Product Innovation
The global nicotine industry is undergoing a profound transformation driven by shifting consumer tastes and evolving regulations. From shisha to nicotine pouches, flavor innovation is creating new opportunities across different product segments, redefining consumer preferences and shaping the future of nicotine worldwide.
Jul.09
U.S. Convenience Store Association Urges Trump Administration: Expedite Product Approvals, Strengthen Enforcement, Crack Down on Illegal Chinese E-Cigarettes
U.S. Convenience Store Association Urges Trump Administration: Expedite Product Approvals, Strengthen Enforcement, Crack Down on Illegal Chinese E-Cigarettes
The National Association of Convenience Stores (NACS) and four major retail groups urged the Trump administration to curb illegal Chinese e-cigarettes, citing heavy losses for compliant retailers. They called on the FDA to speed up product approvals and push for stricter customs checks and DOJ prosecutions.
Jul.21 by 2FIRSTS.ai
Polish E-Cigarette Association Warns of Tax Hike Risks: Could Drive Users Back to Traditional Tobacco
Polish E-Cigarette Association Warns of Tax Hike Risks: Could Drive Users Back to Traditional Tobacco
The Polish E-Cigarette Association warns that the proposed tax hike on e-cigarette devices will raise prices, making them less competitive and pushing consumers back to traditional tobacco. The new tax could increase prices from $11-16 to $19-24. The association plans to challenge the policy legally and internationally, criticizing the lack of fair regulation.
Aug.05 by 2FIRSTS.ai
Imperial Responds to 2Firsts: Disappointed by FDA Denial of blu Product
Imperial Responds to 2Firsts: Disappointed by FDA Denial of blu Product
2Firsts interviewed Imperial Brands on FDA’s blu denial. ITG Brands responded with disappointment, vowing to pursue a fair, science-based review.
Aug.22